selamectin and Ear-Diseases

A clinical field investigation was conducted to evaluate the safety and efficacy of 10% imidacloprid/2.5% moxidectin for the treatment of ear mites (Otodectes cynotis) in dogs. The study was a multi-centered, blinded, positive controlled, randomized clinical trial conducted under field conditions with privately owned pets. A total of 17 veterinary clinics enrolled cases for the study. An otoscopic examination was performed to confirm the presence of O. cynotis residing in the ear of the dog prior to enrollment. A single-dog household was enrolled in the study if the dog had 5 or more ear mites and an acceptable physical examination. A multi-dog household was eligible if at least one dog in the household had 5 or more mites and all dogs in the household had acceptable physical exams and met the inclusion criteria. Qualified households were randomly assigned to treatments to receive either 10% imidacloprid+2.5% moxidectin topical solution or topical selamectin solution (positive control product) according to a pre-designated enrollment ratio of 2:1, respectively. If more than one dog in a multiple dog household had adequate numbers of ear mites, one dog was randomly selected to represent the household for efficacy evaluation prior to treatment. Treatments were administered twice per label and dose banding directions for each product approximately 28 days apart (Days 0 and 28), by the dog's owner at the study site. All dogs in a household were treated on the same day and with the same product. The owners completed a post-treatment observation form one day after each treatment. Post-treatment otoscopic examinations were performed by the investigators or attending veterinarian on Days 28 and 56. Physical examinations were performed on Days 0 and 56. One hundred and four (104) households were evaluated for efficacy on SD 28, and 102 households were evaluated for efficacy on SD 56. The dogs' ages ranged from 2 months to 16 years. A total of 247 dogs were evaluated for safety. Percent efficacy was based on the percentage of dogs cleared of ear mites. Mite clearance on Day 28 was 71% for the imidacloprid+moxidectin group and 69% for the selamectin group. Mite clearance on Day 56 was 82% for the imidacloprid+moxidectin group and 74% for the selamectin group. No serious adverse events associated with either product were observed during the study. The study demonstrated that 10% imidacloprid+2.5% moxidectin applied using two topical treatments, 28 days apart, was saf

Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Ear Diseases; Imidazoles; Insecticides; Ivermectin; Macrolides; Mite Infestations; Neonicotinoids; Nitro Compounds

Efficacy and safety of treatment with imidacloprid 10%+moxidectin 2.5% spot-on (Advocate, Advantage multi; Bayer AG, Leverkusen, Germany) were tested in dogs naturally infested with Sarcoptes scabiei or Otodectes cynotis in a multi-centre, controlled, randomized, blinded field study conducted in France, Germany, Albania and the UK. The study was performed according to a non-inferiority design to demonstrate that the efficacy of imidacloprid/moxidectin spot-on was not inferior to that of a control product containing selamectin (Stronghold spot-on; Pfizer). All Sarcoptes-infested dogs were topically treated twice (days 0 and 28) with the dosage recommended by the respective manufacturer (27 dogs with imidacloprid/moxidectin, 26 with selamectin). All Otodectes-infested dogs were treated on day 0 (35 dogs with imidacloprid/moxidectin, 34 with selamectin), and only those still positive on day 28 received a second treatment. Parasitological cure rate in Sarcoptes-infested dogs was 100% for both treatments, while parasitological cures rates in the Otodectes-infested dogs at day 28 and day 56 were 68.6 and 85.7% with imidacloprid/moxidectin, and 64.7 and 88.2% with Stronghold. Non-inferiority of Advocate was confirmed statistically. Clinical assessment of skin lesion scores at day 56 showed that with either product >96% of the dogs treated against sarcoptic mange were improved or cured, the difference between the groups being non-significant. On the basis of a final clinical assessment of lesion scores, 80% of the dogs treated with imidacloprid/moxidectin against otoacariosis and 85.3% of those treated with selamectin were rated cured or improved. Only three mild, possibly drug-related adverse reactions were observed among alI treated animals (two in the imidacloprid/moxidectin group, one in the selamectin group). It is concluded that imidacloprid/moxidectin spot-on is an effective and safe treatment for sarcoptic mange and otoacariosis in the dog.

Topics: Administration, Topical; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Ear Diseases; Female; Imidazoles; Insecticides; Ivermectin; Macrolides; Male; Mite Infestations; Neonicotinoids; Nitro Compounds

The efficacy of a novel avermectin, selamectin (Stronghold, Pfizer), was evaluated against naturally acquired aural infestations of Otodectes cynotis. Selamectin was administered topically in a single spot to the skin of each animal's back at the base of the neck in front of the scapulae at a minimum dosage of 6mgkg(-1). Thirty cats of a cattery of 120 animals with an endemic infestation were treated on days 0 and 30. Including untreated control cats was therefore not possible because of animal welfare consideration. Clinical examination and visualization of mites by otoscopic examination of the external ear canal and microscopic examination of aural debris/exudate were performed twice weekly from days 0 to 30. On day 0 (and day 28 if the ears canals were erythematous), a swab was taken from each canal and sent to bacteriology and mycology units for detection and identification of bacteria (Staphylococcus mainly) and yeast (Malassezia pachydermatis only). Selamectin was safe, parasites were killed before day 3 and eliminated before day 17. Selamectin was 100% effective against natural aural infestations, even if erythema (26-33% of cats) and scratch reflex (23-40% of cats) persisted for 2 weeks after the cats tested negative for mites.

Topics: Administration, Topical; Animals; Cat Diseases; Cats; Ear; Ear Diseases; Female; Ivermectin; Male; Mite Infestations; Mites

:  Two of three groups of Patagonian cavies ( Dolichotis patagonum ) contracted Otodectes cynotis infestations after exposure to mite-infested feral cats. Otodectes cynotis infestations were initially identified in 9 of 10 cavies in group 1. Multiple feral cats with O. cynotis infestations were observed in the vicinity of the Patagonian cavies and were subsequently removed. The Patagonian cavies were initially treated with ivermectin (0.4 mg/kg s.q.) every 2 wk, but ivermectin was discontinued after the third treatment due to injury to one of the Patagonian cavies during capture. Sixteen months after initial treatment, clinical signs of scratching the pinnae, hemorrhagic lesions on the ear margins, head shaking, and O. cynotis mites in the auricular canal were again noted in all Patagonian cavies in group 1. Repeated administration of ivermectin (0.4 mg/kg s.q. every 2 wk for three treatments) failed to eliminate the mites in two of the Patagonian cavies. Selamectin administered (20 mg/kg, topically between the shoulder blades) to all Patagonian cavies eliminated the mite infestation after a single application. The Patagonian cavies remained O. cynotis mite free for 2 yr, until males (group 2) and females (group 3) were separated for population control. Three months after separation, 8 of the 12 females in group 3 again were infestated with O. cynotis mites. Feral cats with O. cynotis infestations were again noted in the vicinity of group 3. A single dose of selamectin applied topically eliminated all mites in all treated Patagonian cavies. Group 2 was not exposed to feral cats and remained mite free.

Topics: Animals; Ear Diseases; Female; Insecticides; Ivermectin; Male; Mite Infestations; Mites; Rodentia

The aim of this study was evaluate the efficacy of the use of selamectine in the treatment of O. cynotis in Van Cats.. The material of this study comprised of 30 Van Cat which were infected.. In the clinical examination; restlessness, head shaking, scratching at the ears and wax in both ears with brown-black colored cerumens were found. In the otoscopic examination and analysing the samples, O. cynotis was determined. For treatment, single dose selamectin was given. At the 15th and 30th day after treatment, otoscopic and microscopic examinations were repeated. In the 15th day after the treatment, it was found that clinical symptoms seen in the animals were significantly reduced, only the cerumens in 4 cats remained. Besides, at the 30th day, it is found that all the clinical symptoms disappeared in all animals, and with the otoscopic and microscopic examination it was found that there were no agents of O. cynotis.. As a result, due to the ease of usage in cats housed in a crowd and the reason the efficiency for the treatment used as a single dose, selamectine is efficient for treating O. cynotis in Van Cats and it can be used safely.

Topics: Administration, Topical; Animals; Antiparasitic Agents; Cat Diseases; Cats; Cerumen; Ear; Ear Diseases; Female; Ivermectin; Male; Mite Infestations; Psoroptidae

Otacariasis due to Otodectes cynotis (HERING, 1858) is a very frequent disease of the external ear canal in cats. Otodectes cynotis is the most common mange mite in carnivores. Several antiparasiticides are licensed for treatment. The purpose of this study was to evaluate the efficacy of a formulation containing selamectin (Stronghold(®) Spot-on) for eradication of ear mites in cats under field conditions. Sixteen cats with otacariasis, presented in a small animal clinic, were treated with a single spot-on application of selamectin (Stronghold(®) Spot-on, 6-17.3 mg/kg bdw.). On clinical and parasitological assessment days 14 and 28 clinical signs had subsided in ten cats. Furthermore all ear swabs were negative for mites and their developmental stages on D 14 and D 28. Selamectin was a practical and well-tolerated treatment of feline otacariasis for the cats included in this study. It was very well tolerated in all cats, local skin irritations on the neck did not occur.

Topics: Animals; Antinematodal Agents; Cat Diseases; Cats; Ear Diseases; Ivermectin; Mite Infestations; Treatment Outcome